Coronavirus: Merck says deal with Singapore signed; South Korea soon to inoculate pregnant women

Published Oct 06 2021 at 6:34 AM GMT
  • Merck on Wednesday announced it had entered into an agreement with Singapore to provide molnupiravir, an investigational antiviral drug to treat Covid-19, once it is authorised or approved.
  • Molnupiravir is designed to introduce errors into the genetic code of the virus and would be the first oral antiviral medication for Covid-19.
  • Merck is seeking approval by the US Food and Drug Administration for the pill.
  • Singapore’s health ministry did not immediately respond to a request for confirmation of….



  • Published Oct 6, 2021 6:34 AM GMT